ENANTA PHARMACEUTICALS, INC Interest Expense
ENANTA PHARMACEUTICALS, INC (ENTA) reported Interest Expense of $2.35 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-08-07
- ENANTA PHARMACEUTICALS, INC interest expense for the quarter ending 2024-06-30 was $2.35M, a 17.93% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC interest expense for the quarter ending 2024-03-31 was $2.56M.
- ENANTA PHARMACEUTICALS, INC interest expense for the quarter ending 2023-12-31 was $3.44M.
- ENANTA PHARMACEUTICALS, INC interest expense for the quarter ending 2023-09-30 was $3.15M.
- ENANTA PHARMACEUTICALS, INC interest expense for fiscal 2023 was $5.15M.
- ENANTA PHARMACEUTICALS, INC interest expense for fiscal 2022 was $0.00.
- ENANTA PHARMACEUTICALS, INC interest expense for fiscal 2021 was $0.00.
- ENANTA PHARMACEUTICALS, INC interest expense for fiscal 2017 was $40.00K, a 11.11% decline from fiscal 2016.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $2.35M 10-Q · filed 2024-08-07 | $4.92M derived: sum of 2 quarters · filed 2024-08-07 | $8.36M 10-Q · filed 2024-08-07 | $11.51M derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | $2.56M 10-Q · filed 2024-05-08 | $6.00M 10-Q · filed 2024-05-08 | $9.15M derived: sum of 3 quarters · filed 2024-05-08 | $11.15M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-12-31 | $3.44M 10-Q · filed 2024-02-08 | $6.59M derived: sum of 2 quarters · filed 2024-02-08 | $8.59M derived: sum of 3 quarters · filed 2024-08-07 | $8.59M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-09-30 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22 | $5.15M derived: sum of 2 quarters · filed 2024-08-07 | $5.15M derived: sum of 3 quarters · filed 2024-08-07 | $5.15M 10-K · filed 2023-11-22 |
| 2023-06-30 | $2.00M 10-Q · filed 2024-08-07 | $2.00M derived: sum of 2 quarters · filed 2024-08-07 | $2.00M 10-Q · filed 2024-08-07 | $2.00M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 3 quarters · filed 2024-05-08 | $0.00 derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $0.00 10-Q · filed 2024-02-08 | $0.00 derived: sum of 2 quarters · filed 2024-02-08 | $0.00 derived: sum of 3 quarters · filed 2024-02-08 | |
| 2022-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22 | $0.00 derived: sum of 2 quarters · filed 2023-11-22 | $0.00 10-K · filed 2023-11-22 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | ||
| 2021-09-30 | $0.00 10-K · filed 2023-11-22 | |||
| 2017-12-31 | $9.00K 10-Q · filed 2018-02-09 | $18.00K derived: sum of 2 quarters · filed 2018-02-09 | $29.00K derived: sum of 3 quarters · filed 2018-02-09 | $37.00K derived: sum of 4 quarters · filed 2018-02-09 |
| 2017-09-30 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $20.00K derived: sum of 2 quarters · filed 2017-12-11 | $28.00K derived: sum of 3 quarters · filed 2017-12-11 | $40.00K 10-K · filed 2017-12-11 |
| 2017-06-30 | $11.00K 10-Q · filed 2017-08-09 | $19.00K derived: sum of 2 quarters · filed 2017-08-09 | $31.00K 10-Q · filed 2017-08-09 | $42.00K derived: sum of 4 quarters · filed 2018-02-09 |
| 2017-03-31 | $8.00K 10-Q · filed 2017-05-10 | $20.00K 10-Q · filed 2017-05-10 | $31.00K derived: sum of 3 quarters · filed 2018-02-09 | $42.00K derived: sum of 4 quarters · filed 2018-02-09 |
| 2016-12-31 | $12.00K 10-Q · filed 2018-02-09 | $23.00K derived: sum of 2 quarters · filed 2018-02-09 | $34.00K derived: sum of 3 quarters · filed 2018-02-09 | $45.00K derived: sum of 4 quarters · filed 2018-02-09 |
| 2016-09-30 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $22.00K derived: sum of 2 quarters · filed 2017-12-11 | $33.00K derived: sum of 3 quarters · filed 2017-12-11 | $45.00K 10-K · filed 2017-12-11 |
| 2016-06-30 | $11.00K 10-Q · filed 2017-08-09 | $22.00K derived: sum of 2 quarters · filed 2017-08-09 | $34.00K 10-Q · filed 2017-08-09 | $36.00K derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | $11.00K 10-Q · filed 2017-05-10 | $23.00K 10-Q · filed 2017-05-10 | $25.00K derived: sum of 3 quarters · filed 2017-12-11 | $27.00K derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-12-31 | $12.00K 10-Q · filed 2017-02-09 | $14.00K derived: sum of 2 quarters · filed 2017-12-11 | $16.00K derived: sum of 3 quarters · filed 2017-12-11 | $18.00K derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $4.00K derived: sum of 2 quarters · filed 2017-12-11 | $6.00K derived: sum of 3 quarters · filed 2017-12-11 | $8.00K 10-K · filed 2017-12-11 |
| 2015-06-30 | $2.00K 10-Q · filed 2016-08-09 | $4.00K derived: sum of 2 quarters · filed 2016-08-09 | $6.00K 10-Q · filed 2016-08-09 | $10.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2015-03-31 | $2.00K 10-Q · filed 2016-05-10 | $4.00K 10-Q · filed 2016-05-10 | $8.00K derived: sum of 3 quarters · filed 2016-12-09 | $13.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-12-31 | $2.00K 10-Q · filed 2016-02-09 | $6.00K derived: sum of 2 quarters · filed 2016-12-09 | $11.00K derived: sum of 3 quarters · filed 2016-12-09 | $15.00K derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-09-30 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09 | $9.00K derived: sum of 2 quarters · filed 2016-12-09 | $13.00K derived: sum of 3 quarters · filed 2016-12-09 | $18.00K 10-K · filed 2016-12-09 |
| 2014-06-30 | $5.00K 10-Q · filed 2015-08-10 | $9.00K derived: sum of 2 quarters · filed 2015-08-10 | $14.00K 10-Q · filed 2015-08-10 | $22.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2014-03-31 | $4.00K 10-Q · filed 2015-05-08 | $9.00K 10-Q · filed 2015-05-08 | $17.00K derived: sum of 3 quarters · filed 2015-12-11 | $24.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-12-31 | $5.00K 10-Q · filed 2015-02-06 | $13.00K derived: sum of 2 quarters · filed 2015-12-11 | $20.00K derived: sum of 3 quarters · filed 2015-12-11 | $29.00K derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-09-30 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $15.00K derived: sum of 2 quarters · filed 2015-12-11 | $24.00K derived: sum of 3 quarters · filed 2015-12-11 | $31.00K 10-K · filed 2015-12-11 |
| 2013-06-30 | $7.00K 10-Q · filed 2014-08-12 | $16.00K derived: sum of 2 quarters · filed 2014-08-12 | $23.00K 10-Q · filed 2014-08-12 | |
| 2013-03-31 | $9.00K 10-Q · filed 2014-05-12 | $16.00K 10-Q · filed 2014-05-12 | ||
| 2012-12-31 | $7.00K 10-Q · filed 2014-02-13 | |||
| 2011-09-30 | $3.16M 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |